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With rapidly increasing functionality, affordability and ownership of mobile digital 
technologies, the field of mobile health (mHealth) has proliferated in recent years. There is a 
growing recognition of mHealth’s tremendous potential to enrich care and management of a 
range of physical and mental health problems across the globe. A successful implementation 
of effective mHealth initiatives would also eliminate barriers such as financial hardships and 
poor access to care, for example in remote areas that may be hard to reach.  
A number of studies, including SIMPle (Hidalgo-Mazzei et al., 2015) and CLIMB 
(Biagianti et al., 2016), have already established that the remote, active or passive, high 
frequency and real time data from mobile digital technologies, such as smartphones, offer 
unparalleled opportunities to address specific clinical challenges, identify unmet needs and 
deliver interventions in mental health disorders such as schizophrenia and bipolar disorder 
(BD). Faurholt-Jepsen et al. (in this issue) add yet another domain to mHealth by raising the 
possibility that mobile digital technologies capable of providing ‘unbiased estimates of 
behavioural activities’ may provide a diagnostic marker of BD.  
Faurholt-Jepsen and colleagues examined whether automatically generated objective 
smart phone data collected over a 12 weeks period from adults with a clinical diagnosis of 
BD (n=29) differentiated them from healthy adults (n=37).  They found an increase in the use 
of smart phone and communicative activities (the number of text messages sent and received 
per day, the duration of phone calls) during the euthymic, depressive, manic or mixed states 
(and overall) and a decrease in the amount of time the screen was ‘on’ per day during the 
euthymic and depressive states (and overall) in the BD group relative to the healthy control 
group.   
So what do the findings of Faurholt-Jepsen et al.’s study actually mean for clinical 
psychiatry and mHealth initiatives? Can we really use smart phone data to diagnose BD? The 
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findings certainly offer a novel method for quantifying behavioural and communication 
patterns in relation to specific mood states in BD and appear promising in showing a 
difference in automatically generated smart phone data between the BD and healthy groups, 
with a high sensitivity (i.e. the probability of BD being identified in those with a BD 
diagnosis = .92).  Specificity, however, was rather low (.39), and this should be considered a 
significant issue for any potential diagnostic marker. Furthermore, as discussed by Faurholt-
Jepsen and colleagues themselves, the observed increase in some of the phone use parameters 
was possibly triggered by a change in the behaviours of others, and did not index a true BD-
linked change in patients’ behavioural activities. For example, a higher number of texts 
received or sent per day by BD patients, relative to healthy controls, may simply reflect the 
concerns of their relatives or carers. If so, this may or may not be seen for those with a 
probable BD diagnosis but still to be formally diagnosed.   
It is obvious that further data from ongoing (Kessing et al., 2017) and future 
longitudinal studies, especially those that include at-risk groups, are required to robustly 
assess the utility of objective smart phone data as a potential diagnostic marker of BD before 
the smart phone parameters investigated by Faurholt-Jepsen et al. could potentially replace, 
or even meaningfully aid, the current interview-based diagnosis of BD.  It is hoped that other 
phone data such the voice characteristics or speech patterns would add, especially to negative 
predictive value, and increase specificity of smart phone data as a diagnostic marker of BD.  
It is further hoped that by then the field in general would also be better equipped (for example 
with patient facing apps, capacity to achieve scalability and implementation and to deal 
effectively with confidentiality and trust issues) to realise full potential of mHealth and 




Declaration of interest 
The author reports no conflicts of interest. The author alone is responsible for the content and 
writing of the paper. 
 
Funding 
This research received no specific grant from any funding agency in the public, commercial, 




Biagianti B, Hidalgo-Mazzei D, Meyer N (2017). Developing digital interventions for people 
living with serious mental illness: perspectives from three mHealth studies. Evidence 
Based Mental Health 20(4):98-101.  
Biagianti B, Schlosser D, Nahum M, et al. (2016) Creating Live Interactions to Mitigate 
Barriers (CLIMB): a mobile iIntervention to improve social functioning in people 
with chronic psychotic disorders. JMIR Mental Health 3:e52. 
Faurholt-Jepsen M, Busk J, Þórarinsdóttir H et al. (2019). Smartphone data as a potential 
diagnostic marker of bipolar disorder. Australian and New Zealand Journal of 
Psychiatry. 
Hidalgo-Mazzei D, Mateu A, Reinares M, et al. (2016) Psychoeducation in bipolar disorder 
with a SIMPLe smartphone application: feasibility, acceptability and satisfaction. 
Journal of Affective Disorders 200:58-66. 
Kessing LV, Munkholm K, Faurholt-Jepsen M et al. (2017). The Bipolar Illness Onset study: 
research protocol for the BIO cohort study. BMJ Open 7, e015462. 
